mRNA Vaccines and Therapeutics Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global mRNA Vaccines and Therapeutics Market
Research and Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global mRNA Vaccines and Therapeutics Market
Research Report 2023-2028 According to the
latest report by IMARC Group, titled "mRNA
Vaccines and Therapeutics Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028," the global mRNA vaccines and
therapeutics market size reached US 56.1 Billion
in 2022. Messenger Ribonucleic Acid (mRNA) is a
single-stranded RNA molecule that plays a vital
role in human biology, especially in protein
synthesis. Numerous mRNA vaccines and
therapeutics are now available in the market that
are administered in the human body to trigger
virus-detecting immune sensors. This is executed
to induce the production of antibodies that
further bind to the potential pathogens. These
solutions use genetic information to produce
viral antigen proteins within the cells and
provide acquired immunity through an RNA
containing vector, such as lipid nanoparticles.
Their use aids in boosting the immunity of the
body by improving B- and T-cell
responses. Request for a PDF sample of this
report https//www.imarcgroup.com/mrna-vaccines-t
herapeutics-market/requestsample

4
Report Description and Highlights
Report Description
Global mRNA Vaccines and Therapeutics Market
Trends mRNA vaccines represent a promising
alternative to conventional vaccines due to their
high potency, capacity for rapid development and
potential for low-cost manufacture. Along with
this, there has been a rise in the requirement of
vaccines and therapeutics for the treatment of
various viral infections, such as Ebola and Human
Immunodeficiency Virus (HIV). Since these
therapeutics are considered to be more effective
against pathogens due to their enhanced
immunogenicity, numerous private and public
companies are heavily investing in extensive
research and development (RD) activities in the
field of biotechnology for vaccine development
and protein replacement therapy using mRNA.
Additionally, on account of the outbreak of the
coronavirus disease (COVID-19) pandemic, numerous
companies are currently engaging in the
development of a vaccine to curb the transmission
of the virus, thereby creating a positive outlook
for the market. Moderna, Inc. is one such leading
mRNA technology firm that is actively invested in
the development of the mRNA-1273 vaccine against
the novel coronavirus (SARS-CoV-2). It has
registered positive interim results in its Phase
1 study and has already proceeded with the Phase
3 study of mRNA-1273 that is being conducted in
collaboration with the NIH and BARDA. The market
is further driven by the significant improvements
in the lipid nanoparticle formulations for
in-vivo systemic delivery of mRNA.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
is anticipated to reach a value of US 66.2
Billion by 2028. View Report TOC, Figures and
Tables https//www.imarcgroup.com/mrna-vaccines-t
herapeutics-market

6
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Vaccine Type
• Self-amplifying mRNA-Based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines
•  
• Breakup by Treatment Type
• Bioengineered Vaccine
• Gene Therapy
• Gene Transcription
• Cell Therapy
• Monoclonal Antibody
• Others
• Breakup by Vaccine Manufacturing
• In-House
• Out-Sourced

7
Report Description and Highlights
Report Description

• Breakup by Application
• Cancer
• Infectious Disease
• Gene Editing
• Protein Replacement
•  
• Breakup by End-User
• Hospitals and Clinics
• Research Organizations
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

8
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Arcturus Therapeutics Inc
• BioNTech SE
• CureVac AG
• eTheRNA immunotherapies NV
• ethris GmbH
• GlaxoSmithKline PLC
• Moderna Therapeutics Inc
• Translate Bio Inc
• Argos Therapeutics, Inc
• Sangamo Therapeutics Inc
• Pfizer Inc
• etc
•  

9
Key Questions Answered in the Report
Report Description

• What was the size of the global mRNA vaccines and
  therapeutics market in 2022?
• What is the expected growth rate of the global
  mRNA vaccines and therapeutics market during
  2023-2028?
• What are the key factors driving the global mRNA
  vaccines and therapeutics market?
• What has been the impact of COVID-19 on the
  global mRNA vaccines and therapeutics market?
• What is the breakup of the global mRNA vaccines
  and therapeutics market based on the vaccine
  type?
• What is the breakup of the global mRNA vaccines
  and therapeutics market based on the treatment
  type?
• What is the breakup of the global mRNA vaccines
  and therapeutics market based on vaccine
  manufacturing?
• What is the breakup of the global mRNA vaccines
  and therapeutics market based on the application?
• What is the breakup of the global mRNA vaccines
  and therapeutics market based on the end-user?
• What are the key regions in the global mRNA
  vaccines and therapeutics market?
• Who are the key players/companies in the global
  mRNA vaccines and therapeutics market?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Introduction to mRNA
Vaccines and Therapeutics    5.1    History of
mRNA Vaccines and Therapeutics Development   
5.2    Incidence and Prevalence of Chronic
Diseases and Major Infectious Diseases    5.3  
 Prevention and Treatment Using mRNA Vaccines and
Therapeutics    5.3.1 mRNA Modifications

11
Table of Contents
Report Description
    5.3.2 mRNA Efficiencies     5.3.3
Adjuvant/Stimulant and Carrier Technologies for
mRNA-Based Vaccines     5.3.4 Carriers for
mRNA-Based Protein and Antibody Therapeutics 6  
 Global mRNA Vaccines and Therapeutics Market   
6.1    Market Potential Overview    6.2  
 Market Potential    6.3    Impact of COVID-19 
  6.4    mRNA Vaccines in Pipeline7    Market
Breakup by Vaccine Type    7.1  
 Self-amplifying mRNA-Based Vaccines     7.2  
 Conventional Non-Amplifying mRNA-Based
Vaccines8    Market Breakup by Treatment Type 
  8.1    Gene Therapy     8.2    Monoclonal
Antibody     8.3    Gene Transcription     8.4  
 Cell Therapy     8.5    Bioengineered Vaccine 
        Click here to visit the complete table
of content with list of figures and tables
https//www.imarcgroup.com/mrna-vaccines-therapeut
ics-market/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us